Genomics Expertise MOgene specializes in high-end sequencing and genomic services (PacBio Sequel, Illumina NGS, microarrays, qPCR, Nucleic Acid Extraction) with a track record of collaboration across academia, government, and industry, indicating strong cross-sector partnership potential for large-scale research projects and contract R&D services.

Diverse Applications The company serves agriculture, pharmaceutical, and industrial biotech sectors, suggesting opportunities to cross-sell integrated genomic workflows, bioinformatics, and translation services to partner companies pursuing crop improvement, animal genetics, drug discovery, and synthetic biology.

Publication Footprint With over 100 publications stemming from MOgene data, there is demonstrated scientific impact and credibility that can be leveraged in co-development, joint grants, and sponsored research arrangements to attract new academic and government collaborations.

SMB-Ready Scale Operating with 11-50 employees, MOgene appears agile enough for focused partner programs, pilot projects, and tiered service bundles, while potentially requiring scalable bioinformatics support, cloud-based data management, and long-term support contracts as project complexity grows.

Growth Signals Recent news presence and a clear emphasis on full bioinformatics capabilities position MOgene for value-added collaborations in data analysis, interpretation, and regulatory-compliant reporting, offering upsell opportunities for end-to-end genomics solutions and consulting services.